About: Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. operates as a subsidiary of Leonard-Meron Biosciences, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $0.79 (+18.94%)
CTORNASDAQCitius Oncology, Inc.
Loading watchlist status…
Citius Oncology, Inc. share price
CTOR price activity
Last Price
Change (24hr)
USD (%)
Volume
-
Volume (4w avg)
-
Previous Close
N/A
Last Trade
CTOR price performance
32.6%
5D
10.73%
1M
-21.5%
YTD
-58.9%
1Y
CTOR price fundamentals
N/A
Shares Issued
N/A
Earnings Per Share (EPS)
N/A
Dividends Per Share (DPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US-NASDAQ rank
N/ASector Rank
N/ACTOR details
CTOR Market Signals